Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Filings indexed 812 across all filing types
Latest filing 2022-12-06 Regulatory Filings
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Reminder - Lifecare Q3 financial and operational update
Regulatory Filings Classification · 95% confidence The document is a short announcement titled "Reminder - Lifecare Q3 financial and operational update" scheduled for a webcast on December 6, 2022. It explicitly states that the CEO will present the Q3 2022 financial and operational status via a webcast, including a Q&A session. This is not the full financial report (IR or 10-K) nor the initial highlights-only release (ER). It is an announcement about an upcoming presentation/call detailing financial and operational status. Since it is a reminder for an event where financial status will be discussed, and it is very short, it most closely aligns with an announcement regarding an investor event or call. Given the options, it is a precursor to a Call Transcript (CT) or an Investor Presentation (IP) being delivered, but the document itself is an announcement of that event. Because it is a reminder for a presentation/webcast where financial updates will be given, it functions as an announcement of an investor event. However, the closest fit among the provided codes for an announcement about an upcoming presentation/call where financial results are discussed is often categorized under Investor Presentation (IP) if the presentation material is the focus, or Call Transcript (CT) if the call itself is the focus. Since this is a reminder for a presentation/webcast, and the content is about the presentation itself, it is best classified as an announcement related to an Investor Presentation (IP) or potentially a Regulatory Filing (RNS) if no better fit exists. Given the context of financial updates being presented, IP is a strong candidate, but since it is purely an announcement of the time/link for the event, and not the presentation itself, it fits the 'announcement' criteria. If we consider the content is about an upcoming presentation/call, and we must choose from the list, 'IP' (Investor Presentation) or 'CT' (Call Transcript) are related. Since it is a reminder for the event, and not the transcript or the presentation itself, it is a notification. If we strictly follow the 'MENU VS MEAL' rule, this is an announcement about a future event. It is not a standard ER or IR. It is an announcement of a presentation. Therefore, 'IP' (Investor Presentation) is the most relevant category for the subject matter being discussed, even if this specific document is just the announcement/reminder.
2022-12-06 English
Lifecare Q3 report and webcast - Newsletter
Report Publication Announcement Classification · 95% confidence The document is very short (954 characters) and functions as a newsletter or announcement. It explicitly states that Lifecare AS 'will present Q3 2022 financial and operational status in a webcast Tuesday 6 December' and directs the reader to a link for 'Lifecare's latest newsletter'. It is not the full Q3 report (IR) or the transcript of the webcast (CT). Since it is an announcement about the publication/presentation of results and news, it fits best under Report Publication Announcement (RPA), as it announces the upcoming presentation of the Q3 report and directs users to related news/information. It is not a general regulatory filing (RNS) because RPA is more specific for announcing report availability/events.
2022-12-01 English
Lifecare AS launching a UK subsidiary
Regulatory Filings Classification · 95% confidence The document announces a specific corporate action: the incorporation of a new subsidiary in the UK (Lifecare Chemistry Ltd) to formalize a research collaboration. This is a strategic business development announcement, not a routine financial report (like 10-K, IR, ER) or a standard regulatory filing like insider trading (DIRS) or dividend announcement (DIV). It relates to corporate structure and strategic operations. Among the provided codes, 'MANG' (Board/Management Information) is for changes in directors/senior management, which this is not. 'CAP' (Capital/Financing Update) is for fundraising/capital structure changes, which this is not directly. 'RPA' (Report Publication Announcement) is incorrect as it's not announcing another report. The most fitting category for a significant strategic operational move that doesn't fit the specific financial or governance codes is the general 'Regulatory Filings' (RNS) as a catch-all for material, non-standard announcements, or potentially 'TAR' (M&A Activity) if this were part of a larger transaction, but it seems more like a general strategic expansion. Given the options, and since it's a material announcement about corporate structure/strategy that isn't explicitly covered elsewhere, RNS (Regulatory Filings) is the safest fallback, although it describes a strategic business move. However, since it is a material announcement published via stock exchange announcement, and it doesn't fit the specific financial or governance categories, RNS is the appropriate general regulatory category.
2022-11-08 English
Lifecare AS – New share capital registered
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces that a 'New share capital [is] registered' following a previously announced private placement. It details the resulting new registered share capital amount and the total number of shares. This directly relates to a change in the company's capital structure. Based on the definitions, 'Share Issue/Capital Change (Code: SHA)' is the most appropriate classification, as it covers changes to the capital structure resulting from share issuance.
2022-11-03 English
Cancellation of subsequent offering by Lifecare AS
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the 'Cancellation of subsequent offering by Lifecare AS'. This action relates directly to a financing activity (the subsequent offering) that was previously announced. The content discusses the decision to cancel the offering based on market conditions following a prior private placement. This falls under the category of updates on company fundraising, financing activities, or capital structure changes, which corresponds to the Capital/Financing Update (CAP) code. It is not a full report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific corporate finance decision.
2022-11-03 English
Key information relating to subsequent offering by Lifecare AS
Capital/Financing Update Classification · 98% confidence The document explicitly discusses a 'subsequent offering' of new shares, detailing the subscription price, maximum number of shares, and key dates related to the offering (Ex-date, Record date). This content directly relates to fundraising, financing activities, and changes in the capital structure. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV).
2022-10-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.